Sciensus, a Burton-based technology-enabled pharma services business managing the complex medicine needs of more than 250,000 chronic, rare and cancer patients, has reached an agreement to acquire Vinehealth, a cancer patient and physician support tool.
Founded by Rayna Patel, formerly an NHS physician, and Georgina Kirby, a leading data scientist, Vinehealth has grown to become the top-rated cancer support app. It is underpinned by best-in-class technology trusted by patients, physicians, life science companies, and regulators, with support and approvals from the NHS, FDA, MHRA, and EU-MDR.
In recent years Sciensus has invested heavily to build an integrated portfolio of powerful patient engagement and real world evidence solutions to enhance patient connectivity and insight. Centred on the Sciensus InTouch app, these tools support more personalised care and enhanced patient outcomes. Every day thousands of patients use the app to help manage their condition.
The addition of Vinehealth further expands Sciensus’ digital platform. Sciensus will accelerate Vinehealth’s expansion into new geographies and therapeutic areas beyond cancer to support patients worldwide.
Darryn Gibson, CEO of Sciensus, said: “Vinehealth presents a rare and exciting opportunity to acquire a fast-growing, highly innovative business, which is transforming cancer patient outcomes and will significantly strengthen our digital insight offerings.
“We look forward to welcoming Rayna, Georgina, and their team to Sciensus and working together to enable cancer patients to be even more engaged with their treatment.”
The founders of Vinehealth said: “This deal marks an important milestone for Vinehealth. Uniting with Sciensus will extend our reach to patients by leveraging their patient network, and relationships with all the leading pharmaceutical companies and healthcare practitioners.
“Together, we’re poised to enhance the patient experience and generate meaningful patient insights through best-in-class patient support programmes and rich longitudinal real-world data to drive advancements in chronic disease patient support.”
